Table 6.
Compound | Inhibition (μM) | Ref. |
---|---|---|
RNaseHi-1 | 15 | 426 |
RNaseHi-2 | 1 | 403 |
RNaseHi-3 | 50 | 403 |
RNaseHi-4 | 3.5 | 432 |
RNaseHi-5 | 1.2 | 437 |
RNaseHi-6 | 2.7 | 438 |
RNaseHi-7 | 0.65 | 441 |
RNaseHi-8 | 0.43 | 439,440 |
RNaseHi-9 | >50 | 439,440 |
RNaseHi-10 | >50 | 439,440 |
RNaseHi-11 | >50 | 439,440 |
RNaseHi-12 | >50 | 439 |
RNaseHi-13 | 0.061 | 421 |
RNaseHi-14 | 0.15 | 444 |
RNaseHi-15 | 0.11 | 444 |
RNaseHi-16 | 0.045 | 444 |
RNaseHi-17 | 10 | 445 |
RNaseHi-18 | 11 | 445 |
RNaseHi-19 | 0.05 | 446 |
RNaseHi-20 | >10 | 446 |
RNaseHi-21 | 0.2 | 446 |
AZT-MP | 50 | 431 |
BTDBA | 3.2 | 436 |
GSK5750 | 0.33 | 445 |
Manicol | 1.5 | 427 |
RDS 1643 | 13 | 447 |
β-Thujaplicinol | 0.2 | 427 |